Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage : Formulation Optimization and in Vitro/in Vivo Evaluation of Nanosized Poorly Water-Soluble Compounds

DOI Web Site Web Site PubMed 被引用文献3件 参考文献47件
  • Komasaka Takao
    Medicinal Chemistry Research Laboratories I, Mitsubishi Tanabe Pharma Corporation
  • Fujimura Hisako
    Safety Research Laboratories, Mitsubishi Tanabe Pharma Corporation
  • Tagawa Toshiaki
    Safety Research Laboratories, Mitsubishi Tanabe Pharma Corporation
  • Sugiyama Akio
    Safety Research Laboratories, Mitsubishi Tanabe Pharma Corporation
  • Kitano Yasunori
    Medicinal Chemistry Research Laboratories I, Mitsubishi Tanabe Pharma Corporation

書誌事項

タイトル別名
  • Practical Method for Preparing Nanosuspension Formulations for Toxicology Studies in the Discovery Stage: Formulation Optimization and <i>in Vitro</i>/<i>in Vivo</i> Evaluation of Nanosized Poorly Water-Soluble Compounds

この論文をさがす

抄録

The present study aimed to develop a practical method for preparing nanosuspension formulations of poorly water-soluble compounds for enhancing oral absorption in toxicology studies in the discovery stage. To obtain a suitable nanosuspension formulation for the intended purpose, formulations were optimized with a focus on the following characteristics: i) containing a high drug concentration, ii) consisting of commonly used excipient types in proper quantities for toxicology studies, iii) having long-term stability, and iv) having versatility for use with diverse compounds. Test compounds were milled with various excipients by wet media milling methods using a mixer mill (10 mg/batch) and a rotation/revolution mixer (0.5 g/batch). As a result, 100 mg/mL nanosuspensions of all 11 test compounds could be prepared with an optimized dispersing agent, 0.5% hydroxypropyl methylcellulose (HPMC) (3 cP)–0.5% Tween 80. Notably, it was found that the molecular weight of HPMC influenced not only particle size but also the stability of nanosuspensions and they were stable for 4 weeks at 5°C. The nanosuspensions increased in vitro dissolution rates and provided 3.9 and 3.0 times higher Cmax and 4.4 and 1.6 times higher area under the concentration–time curve from 0–24 h (AUC0–24 h) in rats (oral dose of 300 mg/kg) for cilostazol and danazol, respectively. In conclusion, applying a wet media milling method with the combination of HPMC of a small molecular weight and Tween 80 as a dispersing agent, nanosuspensions can be practically prepared and conveniently utilized for enhancing the oral absorption of poorly water-soluble compounds in toxicology studies in the discovery stage.

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (47)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ